Skip to content

Return on equity at other companies

Arrow Electronics logo
Arrow ElectronicsARW
11.5%+4.8pp
TD SYNNEX logo
TD SYNNEXSNX
11.7%+3.3pp
Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
-132.5%+120pp
Ingram Micro logo
Ingram MicroINGM
8.9%+1.1pp
CNX
PC ConnectionCNXN
9.7%-0.4pp
Scansource logo
ScansourceSCSC
8.1%+0.8pp

Other financials

Income statement

See full
Revenue$182.4M+32.1%
Gross profit$26.3M
Operating income$7.3M
Net income$3.3M-37.5%
EPS (diluted)$1.16

Balance sheet

See full
Cash & equivalents$41.8M+28.7%
Total debt$1.8M-36.3%
Total equity$118.4M+23.9%
Total assets$458.8M+24.0%

Cash flow

See full
Operating cash flow$16.8M+99.0%
CapEx$478.0K-34.4%
Free cash flow$16.3M+112%

Valuation

See full
Market cap$411.74M-10.3%
Enterprise value$371.75M-13.4%
P/E21.3×-0.3×
P/S0.6×-0.3×

Profitability

See full
Gross margin16.1%
Operating margin4.5%
Net margin2.8%-1.4pp
FCF margin8%

Returns & leverage

See full
Debt / equity0.0×
Current ratio1.1×+0.1×

Where this comes from

Calculated from Climb Global Solutions, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Climb Global Solutions, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Climb Global Solutions, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Climb Global Solutions, Inc.'s return on equity?
Climb Global Solutions, Inc. (CLMB) reported return on equity of 18.1% in Q1 2026.
How has Climb Global Solutions, Inc.'s return on equity changed year-over-year?
Climb Global Solutions, Inc.'s return on equity decreased by 26.7% year-over-year, from 24.7% to 18.1%.
What is the long-term trend for Climb Global Solutions, Inc.'s return on equity?
Over 5 years (2020 to 2025), Climb Global Solutions, Inc.'s return on equity has grown at a 15.7% compound annual growth rate (CAGR), from 9.9% to 20.6%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.